Remote Ischemic Preconditioning in Septic Patients
Key facts
- Who runs it
- Universität Münster
- Where
- Germany1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 64 people, planned
- Started
- 11 May 2023
- Planned end
- Jan 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Remote ischemic preconditioning (RIPC)
- Sham RIPC
- Record updated
- 12 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Adult patients (age ≥18 years)
- Critically ill patients with sepsis < 12 hours
- Invasive ventilation for at least 24 hours (propofol-free-sedation) and/or vasopressor therapy
- Unrestricted intensive care for at least 72 hours
- Written informed consent
Who cannot take part
- Kidney transplant in the last 12 months
- Chronic kidney disease with estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73m²
- Pre-existing AKI
- (Glomerulo-)nephritis, interstitial nephritis, vasculitis
- Chronic dialysis dependency
- Oral antidiabetics, sulfonamides or nicorandil
- Pregnancy or breastfeeding
- Do-not-reanimate order
- Participation in another interventional trial involving kidney outcomes within the last 3 months
- Dependency on the investigator or center
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Acute kidney injury is a well-recognized complication in critically ill patients. Up to date there is no clinically established method to reduce the incidence or the severity of acute kidney injury.
Read full original descriptionShow less
Remote ischemic preconditioning (RIPC) will be induced by three cycles of upper limb ischemia.
The aim of the study is to reduce the incidence of AKI by implementing remote ischemic preconditioning (identified by the urinary biomarkers tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7(IGFBP7)
The 2 groups in the trial
- Intervention GroupTreatment being tested
Remote ischemic preconditioning (RIPC) Three Cycles of 5-min upper limb ischemia. If there is no response this will be followed by 2 cycles of 10-min upper-limb ischemia.
Treatment: Remote ischemic preconditioning (RIPC)
- Control GroupSham treatment, for comparison
Three cycles of 5- min upper limb sham ischemia.
Treatment: Sham RIPC
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Remote Ischemic Preconditioning in Septic Patients on Cell Cycle Arrest Biomarkers - the RIPC-ICU Randomized Clinical Trial
- Record updated
- 12 December 2024